GB Patent

GB0031088D0 — Medicaments

Assigned to SmithKline Beecham Ltd · Expires 2001-01-31 · 25y expired

What this patent protects

Piperazine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.

USPTO Abstract

Piperazine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.

Drugs covered by this patent

Patent Metadata

Patent number: GB0031088D0
Jurisdiction: GB
Classification: —
Expires: 2001-01-31
Drug substance claim: No
Drug product claim: No
Assignee: SmithKline Beecham Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.